TY - JOUR
T1 - Remarkable Plasmonic Enhanced Luminescence of Ce3+doped Lanthanide Downconversion Nanoparticles in NIR-II Window by Silver Hole-Cap Nanoarrays
AU - Xu, Jiamin
AU - Fu, Ming
AU - Lu, Yao
AU - Centeno, Anthony
AU - Xu, Jingdong
AU - Xiao, Xiaofei
AU - Zhang, Qiyu
AU - Evers, Koen
AU - Xu, Yunfan
AU - Lim, Rico
AU - Liu, Changxu
AU - Maier, Stefan A.
AU - Oulton, Rupert
AU - Ryan, Mary P.
AU - Xie, Fang
N1 - Publisher Copyright:
© 2024 The Author(s). Advanced Optical Materials published by Wiley-VCH GmbH.
PY - 2024/10/24
Y1 - 2024/10/24
N2 - Lanthanide downconversion nanoparticles (DCNPs) have huge potential in biosensing and imaging applications in the NIR-II window. However, DCNPs inherently suffer from low quantum efficiency, due to low absorption cross-section and the restricted doping concentration of lanthanide ions. In this work, a combined strategy for downconversion luminescence in the NIR-II window is investigated by the integration of Ce3+ ions into the conventional NaYF4: Yb3+, Er3+ DCNPs and incorporation of periodic silver hole-cap coupled Nanoarrays (Ag-HCNAs) simultaneously. Over two orders of magnitude, luminescence enhancement is achieved by the combination of optimized Ce3+ doping and plasmonic effects, compared to NaYF4: Yb3+, Er3+ DCNPs immobilized on the glass substrate. Moreover, 3D Finite-Difference Time-Domain (FDTD) simulations and time-resolved luminescence measurements are combined to gain important insights into the mechanism of downconversion luminescence enhancement. The results show that there is a large electric field enhancement between the Ag nanoholes and the Ag hemisphere cap at 980 nm (excitation enhancement), while the lifetime shortening at 1525 nm revealed an increased radiative decay rate and enhanced quantum yield (emission rate enhancement). The strategy for downconversion luminescence enhancement demonstrated in this work holds a significant potential for advancing the next generation biosensing and bioimaging based on DCNPs in the NIR-II window.
AB - Lanthanide downconversion nanoparticles (DCNPs) have huge potential in biosensing and imaging applications in the NIR-II window. However, DCNPs inherently suffer from low quantum efficiency, due to low absorption cross-section and the restricted doping concentration of lanthanide ions. In this work, a combined strategy for downconversion luminescence in the NIR-II window is investigated by the integration of Ce3+ ions into the conventional NaYF4: Yb3+, Er3+ DCNPs and incorporation of periodic silver hole-cap coupled Nanoarrays (Ag-HCNAs) simultaneously. Over two orders of magnitude, luminescence enhancement is achieved by the combination of optimized Ce3+ doping and plasmonic effects, compared to NaYF4: Yb3+, Er3+ DCNPs immobilized on the glass substrate. Moreover, 3D Finite-Difference Time-Domain (FDTD) simulations and time-resolved luminescence measurements are combined to gain important insights into the mechanism of downconversion luminescence enhancement. The results show that there is a large electric field enhancement between the Ag nanoholes and the Ag hemisphere cap at 980 nm (excitation enhancement), while the lifetime shortening at 1525 nm revealed an increased radiative decay rate and enhanced quantum yield (emission rate enhancement). The strategy for downconversion luminescence enhancement demonstrated in this work holds a significant potential for advancing the next generation biosensing and bioimaging based on DCNPs in the NIR-II window.
KW - lanthanide downconversion nanoparticles (DCNPs)
KW - light-matter interaction
KW - Near Infrared Second (NIR-II)
KW - plasmonics
UR - http://www.scopus.com/inward/record.url?scp=85202602377&partnerID=8YFLogxK
U2 - 10.1002/adom.202400660
DO - 10.1002/adom.202400660
M3 - Article
AN - SCOPUS:85202602377
SN - 2195-1071
VL - 12
JO - Advanced Optical Materials
JF - Advanced Optical Materials
IS - 30
M1 - 2400660
ER -